Illumina lowers outlook due to China sales ban, to cut $100 million in costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
Fierce Biotech3d
Illumina aims to cut $100M in costs following China import ban
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
China hits Illumina with import ban. What does that mean for the San Diego gene sequencer?
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
Trade War Fallout Prompts San Diego’s Illumina to Lower Outlook, Cut $100 Million in Costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.
Illumina sees 2025 EPS of $4.50 after China ban, consensus $4.51
Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...
San Diego Union-Tribune10d
Illumina cuts workforce at San Diego headquarters
Illumina recorded about $4.37 billion in total revenue during the 2024 fiscal year, down about 3% from the previous year. The ...
Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...
Nasdaq3d
Illumina Lowers FY25 Outlook Hurt By China Sales Ban
(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina said ...
Illumina price target lowered to $115 from $135 at Canaccord
Canaccord lowered the firm’s price target on Illumina (ILMN) to $115 from $135 and keeps a Hold rating on the shares. The firm’s target ...
Illumina addresses recent developments in China
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...
China bans imports of Illumina's gene sequencers right after Trump tariff action
China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...
Nasdaq3d
Illumina Unusual Options Activity
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments ...